Pioglitazone hydrochloride

InformationBrilanestrant (GDC-0810, ARN-810） is a potentER-αbinder (ER-α, IC50 = 6.1 nM: ER-β, IC50 = 8.8 nM), a full transcriptional antagonist with no agonism and displays good potency and efficacy in ER-α degradation (EC50 = 0.7 nM) and MCF-7

InformationBrilanestrant (GDC-0810, ARN-810） is a potentER-αbinder (ER-α, IC50 = 6.1 nM: ER-β, IC50 = 8.8 nM), a full transcriptional antagonist with no agonism and displays good potency and efficacy in ER-α degradation (EC50 = 0.7 nM) and MCF-7

InformationBRL-15572 is a5-HT1Dreceptor antagonist withpKiof 7.9, also shows a considerable affinity at 5-HT1A and 5-HT2B receptors, exhibiting 60-fold selectivity over 5-HT1B receptor.In vitroBRL-15572 displays high affinity and selectivity for

BW 755C is a 5-lipoxygenase ( 5-LO ) inhibitor with an IC 50 of 5 μM. BW 755C also inhibits cyclooxygenase ( COX ) with IC 50 s of 0.65 and 1.2 μg/mL against COX-1 and COX-2 , respectivelyIn VivoBW 755C (0.03-10 mg/rat: s.c.: once) inhibits the

BW 755C is a 5-lipoxygenase ( 5-LO ) inhibitor with an IC 50 of 5 μM. BW 755C also inhibits cyclooxygenase ( COX ) with IC 50 s of 0.65 and 1.2 μg/mL against COX-1 and COX-2 , respectivelyIn VivoBW 755C (0.03-10 mg/rat: s.c.: once) inhibits the

Selective microsomal prostaglandin E synthase 1 (mPGES-1) inhibitor.

Selective microsomal prostaglandin E synthase 1 (mPGES-1) inhibitor.

Inhibits PP1 (IC₅₀ = 1.7 &muM) and PP2A (IC₅₀ = 0.

Product descriptionCATPB is a potent, selective free fatty acid receptor 2 (FFA2R/GPR43) antagonist.

Product descriptionCATPB is a potent, selective free fatty acid receptor 2 (FFA2R/GPR43) antagonist.

Product descriptionCATPB is a potent, selective free fatty acid receptor 2 (FFA2R/GPR43) antagonist.

Product descriptionCATPB is a potent, selective free fatty acid receptor 2 (FFA2R/GPR43) antagonist.